Silver Book Fact

“Coronary heart disease spending has increased more than 40% over the past 15 years, and, as a whole, the health improvements have been well worth the costs. Over the entire population, spending on coronary heart disease and its major risk factors has resulted in a life-expectancy increase of 0.62 years, at an incremental cost of $43,600 per year of life gained. Life expectancy following a myocardial infraction has increased by nearly a year, at an incremental cost of $24,800 per life-year gained.”

Rosen A, Cutler D, Norton D, Hu H. The Value of Coronary Heart Disease Care for the Elderly: 1987-2002. Health Affairs. 2007; 26(1): 111-123. https://www.healthaffairs.org/doi/full/10.1377/hlthaff.26.1.111

Reference

Title
The Value of Coronary Heart Disease Care for the Elderly: 1987-2002
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Rosen A, Cutler D, Norton D, Hu H
Volume & Issue
Volume 26, Issue 1
Pages
111-123
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • A year-long study of patients with congestive heart failure found that increased use of medicines increased pharmaceutical costs by 60%; however, hospital costs declined by 78%, producing a net savings…  
  • Development of a neuroprotective drug could potentially reduce disability from stroke by 50%.  
  • In 2001, 86,000 more premature deaths from cardiovascular disease (50,000 men and 36,000 women) would have occurred among Americans age 40 and older without antihypertensive drug therapy.  
  • The age-adjusted stroke mortality rate has decreased 70% since 1950, and 64% since 1972.  
  • Satisfaction rates of heart valve disease patients with their treatment